Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a Scoping Review.
Vanadium compounds are among the most extensively investigated insulin-mimetic agents for diabetes mellitus (DM), with reported effects on glucose homeostasis, lipid metabolism, and insulin-related signaling. However, preclinical evidence remains highly heterogeneous due to differences in compound chemistry and experim...